EDN1 and neoplasm: Both tumour groups hyper-secrete ET-1; however, one upregulates ETA receptors and downregulates ETB receptors slightly, such as ovarian, colon, prostate, pancreatic and renal cell carcinoma, whereas the other upregulates ETB receptors and downregulates ETA receptors, like breast and lung cancers [494].